Stimulation of TLR2 and TLR4 differentially skews the balance of T cells in a mouse model of arthritis
Open accessThe DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.
Abstract
TLRs may contribute to the progression of rheumatoid arthritis through recognition of microbial or host-derived ligands found in arthritic joints. Here, we show that TLR2 and TLR4, but not TLR9, are involved in the pathogenesis of autoimmune arthritis and play distinct roles in the regulation of T cells and cytokines. We investigated the involvement of TLR2, TLR4, and TLR9 in the progression of arthritis using IL-1 receptor antagonist-knockout (IL1rn-/-) mice, which spontaneously develop an autoimmune T cell-mediated arthritis. Spontaneous onset of arthritis was dependent on TLR activation by microbial flora, as germ-free mice did not develop arthritis. Clinical and histopathological evaluation of IL1rn-/-Tlr2-/- mice revealed more severe arthritis, characterized by reduced suppressive function of Tregs and substantially increased IFN-gamma production by T cells. IL1rn-/-Tlr4-/- mice were, in contrast, protected against severe arthritis and had markedly lower numbers of Th17 cells and a reduced capacity to produce IL-17. A lack of Tlr9 did not affect the progression of arthritis. While any therapeutic intervention targeting TLR2 still seems complicated, the strict position of TLR4 upstream of a number of pathogenic cytokines including IL-17 provides an interesting potential therapeutic target for rheumatoid arthritis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Spontaneous development of T cell-mediated autoimmune arthritis in IL1rn–/– mice requires the activation of TLR2 and TLR4 by microbial ligands.174”
From Interaction between microbiota and immunity in health and disease (2020) · cites this paper as [174]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pathogen Recognition and Innate Immunity
Akira, S., Uematsu, S., & Takeuchi, O. (2006) · Cell · doi:10.1016/j.cell.2006.02.015 · Cited by 11,952 · cited 1×
“TLRs are primarily involved in innate immune response to microbial pathogens through recognition of conserved pathogen-associated molecular patterns (1); however, they also contribute to sterile inflammation by sensing the “danger signals,” i.”
BackgroundSelf-citationControl of Regulatory T Cell Development by the Transcription Factor Foxp3
Hori, S., Nomura, T., & Sakaguchi, S. (2003) · Science · doi:10.1126/science.1079490 · Cited by 8,187 · cited 1×
“The major function of Tregs is to inhibit other T cells from mounting an immune attack against self components and to prevent autoimmunity (54, 55).”
BackgroundFoxp3 programs the development and function of CD4+CD25+ regulatory T cells
Fontenot, J. D., Gavin, M. A., & Rudensky, A. Y. (2003) · Nature Immunology · doi:10.1038/ni904 · Cited by 7,745 · cited 1×
“The major function of Tregs is to inhibit other T cells from mounting an immune attack against self components and to prevent autoimmunity (54, 55).”
BackgroundBettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T. B., Oukka, M., Weiner, H. L., & Kuchroo, V. K. (2006) · Nature · doi:10.1038/nature04753 · Cited by 6,992
Harrington, L. E., Hatton, R. D., Mangan, P. R., Turner, H., Murphy, T. L., Murphy, K. M., & Weaver, C. T. (2005) · Nature Immunology · doi:10.1038/ni1254 · Cited by 4,742 · cited 1×
“Recent findings identified IL-17 as a crucial disease-promoting factor in autoimmune disorders and showed an inhibitory effect of IFN-γ on Th17 development from naive T cells (42, 43); however, IL-17 production by effector and memory Th17 cells in the presence of IL-23 was not inhibited by IFN-γ.”
BackgroundA distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17
Park, H., Li, Z., Yang, X. O., Chang, S. H., Nurieva, R., Wang, Y.-H., Wang, Y., Hood, L., Zhu, Z., Tian, Q., et al. (2005) · Nature Immunology · doi:10.1038/ni1261 · Cited by 4,265 · cited 1×
“Recent findings identified IL-17 as a crucial disease-promoting factor in autoimmune disorders and showed an inhibitory effect of IFN-γ on Th17 development from naive T cells (42, 43); however, IL-17 production by effector and memory Th17 cells in the presence of IL-23 was not inhibited by IFN-γ.”
BackgroundInterleukin-12 and the regulation of innate resistance and adaptive immunity
Trinchieri, G. (2003) · Nature Reviews Immunology · doi:10.1038/nri1001 · Cited by 3,927
Veldhoen, M., Hocking, R. J., Atkins, C. J., Locksley, R. M., & Stockinger, B. (2006) · Immunity · doi:10.1016/j.immuni.2006.01.001 · Cited by 3,605 · cited 2×
“Conditioned medium of TLR4-stimulated DCs has been shown to replace IL-6, IL-1β, and TNF-α in Th17 cell differentiation (51).”
BackgroundTransforming growth factor-β induces development of the TH17 lineage
Mangan, P. R., Harrington, L. E., O'Quinn, D. B., Helms, W. S., Bullard, D. C., Elson, C. O., Hatton, R. D., Wahl, S. M., Schoeb, T. R., & Weaver, C. T. (2006) · Nature · doi:10.1038/nature04754 · Cited by 3,087
CpG Motifs in Bacterial DNA and Their Immune Effects
Krieg, A. M. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.100301.064842 · Cited by 2,573
Research works printed but not linked: 2
- Scott, 1981, Br. J. Exp. Pathol., 62, 362
- van de Loo, 1992, J. Rheumatol., 19, 348
Cited by
Items 101–200 of 537
The Varieties of Immunological Experience: Of Pathogens, Stress, and Dendritic Cells
Pulendran, B. (2015) · Annual Review of Immunology · doi:10.1146/annurev-immunol-020711-075049 · Cited by 121
Shimizu, J., Kubota, T., Takada, E., Takai, K., Fujiwara, N., Arimitsu, N. N., Ueda, Y., Wakisaka, S., Tomoko, S., & Suzuki, N. (2016) · PLoS ONE · doi:10.1371/journal.pone.0153746 · Cited by 132
“Indeed, oral intake of Lactobacillus bifidus rapidly induced arthritis in genetically modified germ free mice [16].”
BackgroundToll-like receptors as therapeutic targets for autoimmune connective tissue diseases
Li, J., Wang, X., Zhang, F., & Yin, H. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.03.003 · Cited by 121
“While tlr4−/− mice are protected against severe arthritis, tlr2−/− mice show much more severe arthritis characterized by reduced suppressive function of regulatory T cells and increased IFN-γ production by T effector cells (Abdollahi-Roodsaz et al., 2008).”
BackgroundGene, environment, microbiome and mucosal immune tolerance in rheumatoid arthritis
Catrina, A. I., Deane, K. D., & Scher, J. U. (2014) · Rheumatology · doi:10.1093/rheumatology/keu469 · Cited by 137
Autoimmune host–microbiota interactions at barrier sites and beyond
Ruff, W. E., & Kriegel, M. A. (2015) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2015.02.006 · Cited by 121
The struggle within: Microbial influences on colorectal cancer
Arthur, J. C., & Jobin, C. (2011) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21354 · Cited by 122
Negi, S., Pahari, S., Bashir, H., & Agrewala, J. N. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01142 · Cited by 116
“Intestinal microbes have been implicated in the pathogenesis of many diseases such as rheumatoid arthritis and type 1 diabetes through innate immune pathways (39, 40).”
BackgroundGut Microbiota Perturbations in Reactive Arthritis and Postinfectious Spondyloarthritis
Manasson, J., Shen, N., Ferrer, H. R. G., Úbeda, C., Iraheta, I., Heguy, A., Feldt, J. M. V., Espinoza, L. R., Kutzbach, A. G., Segal, L. N., et al. (2017) · Arthritis & Rheumatology · doi:10.1002/art.40359 · Cited by 121
“response in the host’s intestinal lamina propria, thereby promoting local and systemic inflammation in the form of joint disease (32,33).”
BackgroundGut microbiota and immunity relevance in eubiosis and dysbiosis
Al-Rashidi, H. E. (2022) · Saudi Journal of Biological Sciences · doi:10.1016/j.sjbs.2021.10.068 · Cited by 105
Regulation of TH17 cell differentiation by innate immune signals
Huang, G., Wang, Y., & Chi, H. (2012) · Cellular and Molecular Immunology · doi:10.1038/cmi.2012.10 · Cited by 128
Negative regulation of TLR signaling in myeloid cells—implications for autoimmune diseases
Hamerman, J. A., Pottle, J., Ni, M., He, Y., Zhang, Z., & Buckner, J. H. (2016) · Immunological Reviews · doi:10.1111/imr.12381 · Cited by 109
“Surprisingly, TLR2 deficiency exacerbated disease due to effects on regulatory T cells in this model (27).”
Toll-Like Receptors, Infections, and Rheumatoid Arthritis
Arleevskaya, M. I., Larionova, R., Brooks, W. H., Bettacchioli, É., & Renaudineau, Y. (2019) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-019-08742-z · Cited by 124
Abe, K., Takahashi, A., Fujita, M., Imaizumi, H., Hayashi, M., Okai, K., & Ohira, H. (2018) · PLoS ONE · doi:10.1371/journal.pone.0198757 · Cited by 121
Roelofs, M. F., Wenink, M. H., Brentano, F., Abdollahi‐Roodsaz, S., Oppers‐Walgreen, B., Barrera, P., van Riel, P. L. C. M., Joosten, L. A. B., Kyburz, D., van den Berg, W. B., et al. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.086421 · Cited by 110
“Recently, the role of TLR in arthritis was highlighted in experimental models.”
BackgroundSelf-citationBrown, M. A., & Hatfield, J. K. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00147 · Cited by 108
“Activation through TLR2, 3, 4, and 9 is associated with disease in animal models of RA (Ronaghy et al., 2002; Abdollahi-Roodsaz et al., 2008; Hoffmann et al., 2011; Goh and Midwood, 2012) and TLR4 engagement can overcome the requirement for IL-1β in the serum transfer model of this disease (Choe et…”
BackgroundKoenders, M. I., Devesa, I., Marijnissen, R. J., Abdollahi‐Roodsaz, S., Boots, A. M. H., Walgreen, B., di Padova, F. E., Nicklin, M. J. H., Joosten, L. A. B., & van den Berg, W. B. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23957 · Cited by 109
Self-citationThe essential roles of Toll-like receptor signaling pathways in sterile inflammatory diseases
Lin, Q., Li, M., Fang, D., Fang, J., & Su, S. B. (2011) · International Immunopharmacology · doi:10.1016/j.intimp.2011.04.026 · Cited by 123
Chamorro, S., García-Vallejo, J. J., Unger, W. W. J., Fernandes, R. J., Bruijns, S. C. M., Laban, S., Roep, B. O., 't Hart, B. A., & van Kooyk, Y. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0801155 · Cited by 107
“Furthermore, TLR2 has been shown to participate in the induction of peripheral tolerance (72) and, recently, in the promotion of T regulatory responses leading to protection against autoimmune diseases in vivo (73, 74).”
BackgroundInnate immunity as the trigger of systemic autoimmune diseases
Saferding, V., & Blüml, S. (2019) · Journal of Autoimmunity · doi:10.1016/j.jaut.2019.102382 · Cited by 121
Luo, Y., Tong, Y., Wu, L., Niu, H., Li, Y., Su, L. C., Wu, Y., Bözec, A., Zaiss, M. M., Qing, P., et al. (2023) · Arthritis & Rheumatology · doi:10.1002/art.42616 · Cited by 117
Komatsu, N., & Takayanagi, H. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00077 · Cited by 121
“In addition, a deficiency of Toll-like receptor (TLR)-4 or administration of a TLR-4 antagonist suppresses the development of arthritis in IL-1Ra-deficient mice (Abdollahi-Roodsaz et al., 2008) and CIA (Abdollahi-Roodsaz et al., 2007) by decreasing the number of Th17 cells.”
BackgroundArthritis models: usefulness and interpretation
Bessis, N., Decker, P., Assier, É., Semerano, L., & Boissier, M. (2017) · Seminars in Immunopathology · doi:10.1007/s00281-017-0622-4 · Cited by 111
“In contrast, studies in IL-1Ra-deficient mice suggest TLR2 is protective against inflammatory arthritis [70].”
ResultLoures, F. V., Pina, A., Felonato, M., de Araújo, E. F., Leite, K. R. M., & Calich, V. L. G. (2009) · Infection and Immunity · doi:10.1128/iai.01198-09 · Cited by 102
“Dectin and TLR4 signaling by microbial agonists has been reported to induce prevalent expansion of Th17 cells (1, 22, 34, 37).”
BackgroundLi, Y., Zhang, S., Yin, X.-F., Zhang, M.-X., Qiao, J., Xin, X., Chang, M., Gao, C., Li, Y., & Li, X. (2021) · Journal of Immunology Research · doi:10.1155/2021/6665563 · Cited by 110
“Further, Lactobacillu was successfully used to induce arthritis model because Lactobacillu might result in an imbalance of Th17/Tregs homeostasis by mediating TLR2–TLR4 signaling [24].”
MethodRogier, R., Ederveen, T. H. A., Boekhorst, J., Wopereis, H., Scher, J. U., Manasson, J., Frambach, S. J. C. M., Knol, J., Garssen, J., van der Kraan, P. M., et al. (2017) · Microbiome · doi:10.1186/s40168-017-0278-2 · Cited by 98
“We previously described that arthritis in IL1rn mice is diminished under germ-free (GF) condition [12].”
InfluentialSelf-citationRole of microbiota short-chain fatty acids in the pathogenesis of autoimmune diseases
Rasouli‐Saravani, A., Jahankhani, K., Moradi, S., Gorgani, M., Shafaghat, Z., Mirsanei, Z., Mehmandar‐Oskuie, A., & Mirzaei, R. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114620 · Cited by 107
Abdollahi‐Roodsaz, S., Joosten, L. A. B., Helsen, M. M., Walgreen, B., van Lent, P. L., van den Bersselaar, L. A., Koenders, M. I., & van den Berg, W. B. (2008) · Arthritis & Rheumatism · doi:10.1002/art.24127 · Cited by 97
Self-citationJiang, Y., Jarr, K. J., Layton, C., Gardner, C. D., Ashouri, J. F., Abreu, M. T., & Sinha, S. R. (2021) · Nutrients · doi:10.3390/nu13030890 · Cited by 103
Atkinson, M. A., & Chervonsky, A. (2012) · Diabetologia · doi:10.1007/s00125-012-2672-4 · Cited by 91
“arthritis in IL-1-receptor antagonist-deficient mice) are dependent on the presence of commensal bacteria [39]; (2) the severity of some autoimmune lesions depends on the presence of commensal bacteria [40]; (3) sensitivity to the influence of the microbiota can be linked to specific bacterial lineages [41]; and (4) t…”
BackgroundBabaie, F., Hasankhani, M., Mohammadi, H., Safarzadeh, E., Rezaiemanesh, A., Salimi, R., Baradaran, B., & Babaloo, Z. (2018) · Immunology Letters · doi:10.1016/j.imlet.2018.01.014 · Cited by 101
Pierer, M., Wagner, U. G., Rossol, M., & Ibrahim, S. M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023539 · Cited by 94
“In skg mice, the development of arthritis is Dectin- dependent [3], while in the IL-1ra 2/2 model, disease is critically dependent on TLR-function, namely TLR4 [4][5].”
BackgroundMathis, D., & Benoist, C. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01084.x · Cited by 90
“, arthritis (63, 64, 67), or even with the same model in the hands of different investigators, e.”
BackgroundKomatsu, N., & Takayanagi, H. (2012) · Advances in immunology · doi:10.1016/b978-0-12-394299-9.00002-3 · Cited by 104
“In addition, a deficiency of Toll-like receptor (TLR)-4 or administration of a TLR-4 antagonist suppresses the development of arthritis in IL-1Ra-deficient mice (Abdollahi-Roodsaz et al., 2008) and CIA (Abdollahi-Roodsaz et al.”
Sensors of the innate immune system: their link to rheumatic diseases
Theofilopoulos, A. N., González‐Quintial, R., Lawson, B. R., Koh, Y. T., Stern, M. E., Kono, D. H., Beutler, B., & Baccalà, R. (2010) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2009.278 · Cited by 105
“Spontaneous arthritis in mice that lack the IL-1R antagonist (IL-1Ra) was also reduced in the absence of TLR4”
BackgroundInsights into the Relationship between Toll Like Receptors and Gamma Delta T Cell Responses
Dar, A. A., Patil, R. S., & Chiplunkar, S. V. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00366 · Cited by 111
“TLR4, in contrast, contributes to more severe disease by modulating the Th17 cell population and IL-17 production (99, 100).”
BackgroundBioactivity in an Aggrecan 32‐mer Fragment Is Mediated via Toll‐like Receptor 2
Lees, S., Golub, S. B., Last, K., Zeng, W., Jackson, D. C., SUTTON, P. R. N., & Fosang, A. (2015) · Arthritis & Rheumatology · doi:10.1002/art.39063 · Cited by 98
“Several models of inflammatory arthritis in mice involve TLRmediated synovial activation (9,10,41) that is thought to drive the disease process, and based on the results of those studies, TLR antagonists are in development for”
BackgroundPrimer: Toll-like receptor signaling pathways—what do rheumatologists need to know?
O'Neill, L. A. J. (2008) · Nature Clinical Practice Rheumatology · doi:10.1038/ncprheum0802 · Cited by 99
“Deletion of TLR4 conferred protection against arthritis in a mouse model of spontaneous arthritis (the IL-1 receptor antagonist knockout mouse)”
BackgroundZádori, Z., Király, K. P., Al‐Khrasani, M., & Gyires, K. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108327 · Cited by 99
Rogier, R., Koenders, M. I., & Abdollahi-Roodsaz, S. (2015) · Journal of Immunology Research · doi:10.1155/2015/527696 · Cited by 92
Self-citationRosenbaum, J. T., & Davey, M. P. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30558 · Cited by 93
Retinoic Acid, Leaky Gut, and Autoimmune Diseases
Abdelhamid, L., & Luo, X. (2018) · Nutrients · doi:10.3390/nu10081016 · Cited by 96
“Intestinal microbial dysbiosis is proposed to induce epigenetic modifications that can upregulate TLR expression on APCs [170] and deviate the balance of T-cell subsets [171,172].”
BackgroundThe Role of Regulatory T Cells in Atopic Dermatitis
Agrawal, R., Wiśniewski, J., & Woodfolk, J. A. (2011) · Current problems in dermatology · doi:10.1159/000323305 · Cited by 93
“There is evidence in animal models to suggest that TLR pathways are involved in modulating Tregs [38, 39].”
BackgroundKalinkovich, A., & Livshits, G. (2019) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2019.05.007 · Cited by 93
Knox, N., Forbes, J. D., Peterson, C.-L., Domselaar, G. V., & Bernstein, C. N. (2019) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000000305 · Cited by 95
Immunoregulation by the gut microbiota
Nishio, J., & Honda, K. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-0993-6 · Cited by 95
RETRACTED: Rheumatoid arthritis (RA) and cardiovascular disease
Blum, A., & Adawi, M. (2019) · Autoimmunity Reviews · doi:10.1016/j.autrev.2019.05.005 · Cited by 87
RetractedToll-like receptors and NOD-like receptors in rheumatic diseases
McCormack, W. J., Parker, A. E., & O'Neill, L. A. J. (2009) · Arthritis Research & Therapy · doi:10.1186/ar2729 · Cited by 91
Stimulation of chondrocyte‐mediated cartilage destruction by S100A8 in experimental murine arthritis
van Lent, P. L. E. M., Grevers, L., Blom, A. B., Arntz, O. J., van de Loo, F. A. J., van der Kraan, P., Abdollahi‐Roodsaz, S., Srikrishna, G., Freeze, H. H., Sloetjes, A. W., et al. (2008) · Arthritis & Rheumatism · doi:10.1002/art.24074 · Cited by 86
Self-citationChervonsky, A. V. (2013) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a007294 · Cited by 85
“BR mice (Re- hakova et al. 2000; Sinkorova et al. 2008) RA in IL1R-antagonist KO (Abdollahi-Roodsaz et al. 2008) The experiments listed in the table are not exhaustive.”
BackgroundBenson, A., Murray, S. E., Divakar, P., Burnaevskiy, N., Pifer, R., Forman, J., & Yarovinsky, F. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100769 · Cited by 85
Molecular Insight into Gut Microbiota and Rheumatoid Arthritis
Wu, X., He, B., Liu, J., Feng, H., Ma, Y., Li, D., Guo, B., Liang, C., Dang, L., Wang, L., et al. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17030431 · Cited by 94
“[33].”
Chamberlain, N. D., Vila, O. M., Volin, M. V., Volkov, S., Pope, R. M., Swedler, W. I., Mandelin, A. M., & Shahrara, S. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1102977 · Cited by 84
“Further, the data obtained from experimental arthritis models strongly support the role of TLR2 and TLR4 in streptococcal cell wall arthritis (9, 10) while TLR4 has been implicated in collagen-induced arthritis (11) as well as in the IL-1RA model (11, 12).”
BackgroundLee, H. S., Hattori, T., Park, E. Y., STEVENSON, W. C., Chauhan, S. K., & Dana, R. (2012) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.12-9547 · Cited by 87
“Furthermore, TLR4-deficient mice demonstrate decreased infiltration of inflammatory cells, particularly Th17 cells, and reduced production of IL-17 in a rheumatoid arthritis model.(45) TLR4 inhibition also diminishes the production of chemokines such as IL-8/CXCL8 and CCL2, and reduces the infiltration of inflammatory…”
BackgroundCommensal gut flora and brain autoimmunity: a love or hate affair?
Berer, K., & Krishnamoorthy, G. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-0949-9 · Cited by 82
Wong, C. K., Wong, P. T. Y., Tam, L., Li, E. K., Chen, D. P., & Lam, C. W. K. (2009) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2009.04036.x · Cited by 83
Wei, Z., Li, F., & Pi, G. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.812596 · Cited by 86
“This pathway indicates that LPS not only induces innate immune response through TLR4 activation, but also aggravates the existing chronic low-grade inflammation by upregulating proinflammatory cytokines (Huang and Kraus, 2016), conferring OA to a chronic disease state (Scanzello et al., 2008).”
BackgroundInfluentialOral–Gut Microbiota and Arthritis: Is There an Evidence-Based Axis?
Drago, L., Zuccotti, G., Romanò, C. L., Goswami, K., Villafañe, J. H., Mattina, R., & Parvizi, J. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8101753 · Cited by 91
“Thus, gut microbiota have been further confirmed to be a cause of relevant immunological triggers occurring in arthritis pathogenesis [8,60].”
BackgroundTherapeutic efficacy of Tyro3, Axl, and Mer tyrosine kinase agonists in collagen‐induced arthritis
van den Brand, B. T., Abdollahi‐Roodsaz, S., Vermeij, E. A., Bennink, M. B., Arntz, O. J., Rothlin, C. V., van den Berg, W. B., & van de Loo, F. A. J. (2013) · Arthritis & Rheumatism · doi:10.1002/art.37786 · Cited by 77
“TLRs have also been implicated in maintenance of the chronic inflammatory loop in RA synovium (8,9), and TLR-2 and TLR-4 play an important role in arthritis (10,11).”
Self-citationMarijnissen, R. J., Koenders, M. I., Smeets, R. L., Stappers, M. H. T., Nickerson‐Nutter, C. L., Joosten, L. A. B., Boots, A. M. H., & van den Berg, W. B. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30469 · Cited by 84
Self-citationInnate Sensing of the Gut Microbiota: Modulation of Inflammatory and Autoimmune Diseases
Ignacio, A., Morales, C. I., Câmara, N. O. S., & Almeida, R. R. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00054 · Cited by 74
The Multiple Facets of Toll-Like Receptors in Transplantation Biology
Alegre, M., Leemans, J. C., Moine, A. L., Florquin, S., Wilde, V. D., Chong, A. S., & Goldman, M. (2008) · Transplantation · doi:10.1097/tp.0b013e31817c11e6 · Cited by 80
Immunogenetic control of the intestinal microbiota
Marietta, E. V., Rishi, A. R., & Taneja, V. (2015) · Immunology · doi:10.1111/imm.12474 · Cited by 80
Gastrointestinal and Hepatic Disease in Rheumatoid Arthritis
Craig, E. T., & Cappelli, L. C. (2017) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2017.09.005 · Cited by 80
Böhm, M., & Grässel, S. (2012) · Endocrine Reviews · doi:10.1210/er.2011-1016 · Cited by 79
Chamberlain, N. D., Kim, S.-J., Vila, O. M., Volin, M. V., Volkov, S., Pope, R. M., Arami, S., Mandelin, A. M., & Shahrara, S. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2011-201203 · Cited by 82
The microbiome in rheumatology: Where are we and where should we go?
Manasson, J., Blank, R. B., & Scher, J. U. (2020) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2019-216631 · Cited by 80
Viral infection in induction of Hashimotoʼs thyroiditis: a key player or just a bystander?
Mori, K., & Yoshida, K. (2010) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e32833cf518 · Cited by 82
Cell signalling in macrophages, the principal innate immune effector cells of rheumatoid arthritis
Drexler, S. K., Kong, P. L., Wales, J., & Foxwell, B. M. J. (2008) · Arthritis Research & Therapy · doi:10.1186/ar2481 · Cited by 78
Functional profiling of the gut microbiome in disease-associated inflammation
Börnigen, D., Morgan, X. C., Franzosa, E. A., Ren, B., Xavier, R. J., Garrett, W. S., & Huttenhower, C. (2013) · Genome Medicine · doi:10.1186/gm469 · Cited by 67
“For example, Lactobacillus bifidus was shown to trigger arthritis in a mouse model (IL-1-receptor-antagonist-deficient mice), which was specifically driven by an imbalance in T-cell homeostasis and mediated through Toll-like receptor (TLR2 and TLR4) signaling [39].”
BackgroundGut microbiota in autoimmunity: potential for clinical applications
Kim, D.-H., Yoo, S., & Kim, W. (2016) · Archives of Pharmacal Research · doi:10.1007/s12272-016-0796-7 · Cited by 79
“Similarly, Lactobacillus can induce arthritis in IL-1rn mice in a TH17- and TLR4dependent manner (Abdollahi-Roodsaz et al. 2008).”
BackgroundInfluentialHu, S., He, W., Du, X., Yang, J., Wen, Q., Zhong, X., & Ma, L. (2017) · EBioMedicine · doi:10.1016/j.ebiom.2017.08.001 · Cited by 81
Chen, X., Lu, J., An, M., MA, Z., Zong, H.-X., & YANG, J. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.2070 · Cited by 70
TLR2 Promotes Th2/Th17 Responses via TLR4 and TLR7/8 by Abrogating the Type I IFN Amplification Loop
Wenink, M. H., Santegoets, K. C. M., Broen, J. C. A., van Bon, L. G., Abdollahi‐Roodsaz, S., Popa, C. D., Huijbens, R. J. F., Remijn, T., Lubberts, E., van Riel, P. L. C. M., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900713 · Cited by 81
“In the absence of TLR2, uncontrolled inflammation and excessive injury of tissues in response to infections or during autoimmune processes have been observed (21, 23).”
BackgroundSelf-citationGut microbiota and inflammatory joint diseases
Bréban, M. (2016) · Joint Bone Spine · doi:10.1016/j.jbspin.2016.04.005 · Cited by 78
Doonan, J., Tarafdar, A., Pineda, M. A., Lumb, F. E., Crowe, J., Khan, A., Hoskisson, P. A., Harnett, M. M., & Harnett, W. (2019) · Nature Communications · doi:10.1038/s41467-019-09361-0 · Cited by 76
Kolwijck, E., & van de Veerdonk, F. L. (2014) · European Journal of Immunology · doi:10.1002/eji.201344404 · Cited by 69
Wenink, M. H., Santegoets, K. C. M., Roelofs, M. F., Huijbens, R. J. F., Koenen, H. J. P. M., van Beek, R., Joosten, I., Meyer‐Wentrup, F. A. G., Mathsson, L., Rönnelid, J., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900153 · Cited by 72
“Finally, studies in mice revealed that the triggering of TLR aggravates arthritis whereas inhibition of the TLR4 pathways either by genetic knockdown (23) or by addition of TLR antagonists drastically reduced the arthritis incidence and severity (24).”
BackgroundSelf-citationHuang, Q., & Pope, R. M. (2010) · Journal of Leukocyte Biology · doi:10.1189/jlb.0310126 · Cited by 76
Tsai, H., Wu, Y., Liu, X., Xu, Z., Liu, L., Wang, C., Zhang, H., Huang, Y., Wang, L., Zhang, W., et al. (2021) · Advanced Science · doi:10.1002/advs.202102634 · Cited by 69
Lessons from animal models of arthritis over the past decade
Berg, W. (2009) · Arthritis Research & Therapy · doi:10.1186/ar2803 · Cited by 67
Microbiota and Autoimmune Disease: The Hosted Self
Mathis, D. J., & Benoist, C. O. (2011) · Cell Host & Microbe · doi:10.1016/j.chom.2011.09.007 · Cited by 70
Impact of obesity on autoimmune arthritis and its cardiovascular complications
Raemdonck, K. V., Umar, S., Szekanecz, Z., Zomorrodi, R. K., & Shahrara, S. (2018) · Autoimmunity Reviews · doi:10.1016/j.autrev.2018.02.007 · Cited by 69
Intestinal microbiome as a novel therapeutic target for local and systemic inflammation
Uchiyama, K., Naito, Y., & Takagi, T. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.03.006 · Cited by 72
Expression of TLR2, TLR4, and TLR9 in dermatomyositis and polymyositis
Kim, G.-T., Cho, M., Park, Y.-E., Yoo, W. H., Kim, J.-H., Oh, H., Kim, D.-S., Baek, S.-H., Lee, S., Lee, J., et al. (2009) · Clinical Rheumatology · doi:10.1007/s10067-009-1316-7 · Cited by 64
“immune response [14–21].”
BackgroundLi, H., Guan, S., Lu, Y., & Wang, F. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.09.079 · Cited by 64
TLR4 Activation Is Required for IL-17–Induced Multiple Tissue Inflammation and Wasting in Mice
Tang, H., Pang, S., Wang, M., Xiao, X., Rong, Y., Wang, H., & Zang, Y. Q. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903664 · Cited by 63
“Furthermore, TLR4 gene deficiency protects IL-1Ra mice from severe arthritis by reducing the number of pathogenic Th17 cells and the production of IL-17 (30).”
BackgroundCourties, G., Seiffart, V., Présumey, J., Escriou, V., Scherman, D., Zwerina, J., Ruiz, G., Ziętara, N., Jabłońska, J., Weiß, S., et al. (2010) · Blood · doi:10.1182/blood-2010-02-269605 · Cited by 67
Factoring the intestinal microbiome into the pathogenesis of autoimmune hepatitis
Czaja, A. J. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i42.9257 · Cited by 64
Aarts, J., Boleij, A., Pieters, B. C. H., Feitsma, A. L., van Neerven, R. J. J., ten Klooster, J. P., M’Rabet, L., Arntz, O. J., Koenders, M. I., & van de Loo, F. A. J. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.703277 · Cited by 68
“Furthermore, arthritis in these IL1rn−/− mice was diminished under germ-free conditions and was shown to be dependent on the activation of toll-like receptor 4 (TLR4) and subsequent enhanced Th17 differentiation (22).”
BackgroundSelf-citationPattern recognition receptors as potential therapeutic targets in inflammatory rheumatic disease
Mullen, L., Chamberlain, G., & Sacre, S. M. (2015) · Arthritis Research & Therapy · doi:10.1186/s13075-015-0645-y · Cited by 65
“mice, disease severity is reduced [19].”
BackgroundToll-like receptors as targets for immune disorders
Keogh, B., & Parker, A. E. (2011) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2011.03.008 · Cited by 72
Yannaki, E., Παπαδοπούλου, Α., Athanasiou, E., Kaloyannidis, P., Paraskeva, A., Bougiouklis, D., Palladas, P., Yiangou, M., & Anagnostopoulos, Α. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27690 · Cited by 67
Meng, L., Zhu, W., Jiang, C., He, X., Hou, W., Zheng, F., Holmdahl, R., & Lu, S. (2010) · Arthritis Research & Therapy · doi:10.1186/ar3034 · Cited by 67
“TLR2 and 4 were reported to be involved in the chronicity and erosive destruction of streptococcal cell wall induced arthritis and spontaneous arthritis in IL-1 receptor antagonist-knockout mice [8,30,31].”
BackgroundRelationship between intestinal microbiota and colorectal cancer
Çıpe, G., İdiz, U. O., Fırat, Y. D., & Bektaşoğlu, H. K. (2015) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v7.i10.233 · Cited by 70
Prevotella Copri and Microbiota in Rheumatoid Arthritis: Fully Convincing Evidence?
Drago, L. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8111837 · Cited by 67
“gingivalis, and others, such as the segmented filamentous bacteria (SGB) [21], or a particular strain of Lactobacillus bifidus [22] can play an important role in the pathogenesis of RA.”
BackgroundThe biological and clinical importance of the 'new generation' cytokines in rheumatic diseases
Gabay, C., & McInnes, I. B. (2009) · Arthritis Research & Therapy · doi:10.1186/ar2680 · Cited by 71
“Activation of TLR4, which shares common signalling molecules with IL-1R, stimulates the production of IL-23 and IL-17 and regulates the severity of experimental arthritis [135].”
BackgroundLamacchia, C., Palmer, G., Seemayer, C. A., Talabot‐Ayer, D., & Gabay, C. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27235 · Cited by 55
Xiao, Y., Shi, M., Qiu, Q., Huang, M., Zeng, S., Zou, Y., Zhan, Z., Liang, L., Yang, X., & Xu, H. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1501281 · Cited by 58
“Targeted manipulation of DCs could be a powerful tool for combating autoimmune diseases such as rheumatoid arthritis (RA) (11, 12).”
Thompson, K. N., Bonham, K. S., Ilott, N. E., Britton, G. J., Colmenero, P., Bullers, S. J., McIver, L. J., Ma, S., Nguyen, L. H., Filer, A. D., et al. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.abn4722 · Cited by 59
Bielinska, A. U., Makidon, P. E., Janczak, K. W., Blanco, L. P., Swanson, B. J., Smith, D. M., Pham, T., Szabó, Z., Kukowska‐Latallo, J. F., & Baker, J. R. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1301424 · Cited by 59
Metadata
- Authors
- Abdollahi-Roodsaz, S., Joosten, L. A. B., Koenders, M. I., Devesa, I., Roelofs, M. F., Radstake, T. R. D. J., Heuvelmans-Jacobs, M., Akira, S., Nicklin, M. J. H., Ribeiro-Dias, F., & van den Berg, W. B.
- Affiliations
- Radboud University Medical Center (NL)
- Research Institute for Microbial Diseases, The University of Osaka (JP)
- University of Sheffield (GB)
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2008-01-02
- Volume
- 118
- Issue
- 1
- Pages
- 205-216
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC2104479
- OpenAlex
- W2107300453
- Cited by
- 527
- References
- 71
- Citations by year
- 2026: 9 · 2025: 12 · 2024: 16 · 2023: 29 · 2022: 24 · 2021: 31 · 2020: 26 · 2019: 33 · 2018: 31 · 2017: 28 · 2016: 43 · 2015: 33 · 2014: 28 · 2013: 35 · 2012: 39
- FWCI
- 15.30
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Americanae (AECID Library) (submittedVersion, other-oa)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, other-oa)
- Radboud Repository (Radboud University) (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion, other-oa)
- Funders
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- Ministério da Educação
- Dutch Arthritis Association
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- TLR2, TLR4, TLR9, rheumatoid arthritis, autoimmune arthritis, Treg suppressive function, Th17 cells, IL-17, interferon-gamma, interleukin-1 receptor antagonist, germ-free mice, microbiota, T cell differentiation, cytokine production, therapeutic target
- MeSH terms
- Animals, Arthritis, Rheumatoid, Disease Models, Animal, Germ-Free Life, Humans, Lymphocyte Activation, Mice, Inbred BALB C, Mice, Knockout, Interleukin-17, T-Lymphocytes, Regulatory, Toll-Like Receptor 2, Toll-Like Receptor 4, Toll-Like Receptor 9, Mice, Interleukin 1 Receptor Antagonist Protein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.